independence blue cross glp 1 coverage MCT2D Independence Health Group reports solid

2002;365(Pt 2):405-416

Unlike recombinant human growth hormone (rhGH), which was unsuccessful as a growth-promoting agent in children, sermorelins efficacy in stimulating the pituitary gland makes it a viable option for aging individuals

Clinical evidence suggests that modest dose increases (0.250.5 mg jumps) can restore efficacy if plateau occurs

In diseases where amino-acid metabolizing enzymes are dysfunctional or absent (e.g., propionic acidemia and methylmalonic acidemias characterized by neurological symptoms, muscle weakness and low energy) C3 accumulates, and higher blood levels are used as a screening tool